The genus Streptomyces is a major driver of the soil microbial community. These filamentous, exospore-producing bacteria are copious producers of bioactive compounds that are not only used as antibiotics but also affect the soil microbial community in composition and activity. With an average of about 30 different bioactive compounds produced per species, the bacteria use complex regulatory mechanisms that respond to environmental as well as community signals. Understanding these mechanisms will be useful in harnessing the full potential of Streptomyces in biotechnology, e.g., to tackle the antibiotic resistance crisis. This includes the discovery of new antibiotics that are not produced under standard laboratory conditions, as well as being able to modulate the signaling cascades to produce other biotechnology products. As an example, the genus Streptomyces, as one of the few bacterial and archaeal taxa, produces cobalamin de novo through both the oxic and anoxic biosynthesis pathways. This feature adds to the importance of this genus for the soil microbial communities, as well as for applications in fermentation.
No takes yet. Share an insight, caveat, or question.
Höller et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: